Cellectar Biosciences CLRB
NASDAQ CLRB
$1.22 +0.05 (+4.27%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cellectar Biosciences (CLRB) Return on Sales [ROS] (2012 - 2026)

Updated

Analysis

Cellectar Biosciences (CLRB) Return on Sales [ROS] (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Cellectar Biosciences 14.92 Mn -55.86 Mn - -5,395.97%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,395.97%
Dec 31, 2025 -5,832.06%
Sep 30, 2025 -4,310.08%
Jun 30, 2025 -6,859.27%
Mar 31, 2025 -4,673.55%
Dec 31, 2024 -5,218.80%
Sep 30, 2024 -4,192.58%
Jun 30, 2024 -4,166.44%
Mar 31, 2024 -3,752.23%
Dec 31, 2023 -9,012.86%
Sep 30, 2023 -18,418.04%
Jun 30, 2023 -11,395.99%
Mar 31, 2023 -7,018.48%
Dec 31, 2022 -5,034.14%
Sep 30, 2022 -187,691.79%
Jun 30, 2022 -1,545,846.99%
Mar 31, 2022 -1,427,959.77%
Dec 31, 2021 -1,056,535.90%
Sep 30, 2021 -986,382.03%
Jun 30, 2021 -914,823.82%
API Access

Cellectar Biosciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CLRB&period=max&api_key=YOUR_API_KEY